Organization

Hospital de Cruces

1 clinical trial

1 abstract

Clinical trial
Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta
Status: Completed, Estimated PCD: 2018-12-01
Abstract
First-line pembrolizumab plus platinum-pemetrexed in metastatic non-small cell lung cancer: Clinical experience in a Spanish tertiary hospital.
Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Hospital Universitario de Cruces, Hospital Universitario Donostia-Biodonostia, Hospital Universitario Cruces, Cruces University Hospital,